Nanotechnology-Based Strategies for Modulating Epigenetic Dysregulation in Cancer
2026 | NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES (NIJSES) | Pp. 78-83
Epigenetic dysregulation is a defining feature of cancer, driving malignant transformation, tumor progression, and therapeutic resistance through reversible yet heritable alterations in gene expression. Aberrant DNA methylation, histone modifications, and chr...